Dose-dependence of chemical carcinogenicity: Biological mechanisms for thresholds and implications for risk...

Area of Science:

• Toxicology
• Molecular Biology
• Risk Assessment

Background:

• Current regulatory practices for chemical carcinogens are based on outdated understanding of carcinogenesis.
• The default linear, no-threshold approach assumes a simple DNA mutation-cancer relationship.
• Advances in molecular and cellular biology reveal complex protective mechanisms against cancer initiation.

Purpose of the Study:

• To review scientific discoveries and technological advances in chemical carcinogenesis over the past 50 years.
• To highlight the shift from linear to non-linear dose-response models.
• To demonstrate the utility of modern technologies for biologically robust cancer risk assessment.

Main Methods:

• Review of historical scientific literature and technological advancements.
• Analysis of molecular, cellular, and organism-level protective mechanisms.
• Case studies illustrating modern dose-response evaluation techniques.

Main Results:

• Identification of intrinsic cellular processes preventing DNA damage from causing cancer.
• Evidence for non-linear dose-response, including threshold effects, for both genotoxic and non-genotoxic carcinogens at low chemical doses.
• Demonstration that protective mechanisms can mitigate carcinogenesis at low exposure levels.

Conclusions:

• The default linear, no-threshold risk assessment model for chemical carcinogens is challenged by modern scientific understanding.
• Non-linear dose-response relationships are prevalent for both genotoxic and non-genotoxic carcinogens.
• Biologically informed risk assessment using advanced technologies is crucial for accurate chemical safety evaluations.